A review of inherited cancer susceptibility syndromes
Authors:
- Gina R. BrownGBGina R. Brown
- Madeline SimonMSMadeline Simon
- Chris WentlingCWChris Wentling
- Danielle M. SpencerDSDanielle M. Spencer
- Ashley N. ParkerAPAshley N. Parker
- Corey A. RogersCRCorey A. Rogers
- 1 December 2020
- journal article
- review article
- Published by Wolters Kluwer Health in JAAPA
- Vol. 33 (12) , 10-16
Abstract
Inherited cancer syndromes are caused by genetic mutations that place patients at an increased risk for developing cancer. Although most cancers are not caused by genetic inheritance, clinicians must understand these syndromes and be able to recognize their common characteristics. A thorough family history and identification of common patterns as well as specific clinical signs and symptoms can help with early recognition. This article describes symptoms of the more common cancer syndromes, including hereditary breast and ovarian cancer, Li-Fraumeni, Lynch, familial adenomatous polyposis, retinoblastoma, multiple endocrine neoplasia, and von Hippel-Lindau. Important patient education regarding genetic testing also is covered.Keywords
This publication has 33 references indexed in Scilit:
- BRCA1/2 Sequence Variants of Uncertain Significance: A Primer for Providers to Assist in Discussions and in Medical ManagementThe Oncologist, 2013
- Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European expertsGut, 2013
- Genetic and Clinical Features of Multiple Endocrine Neoplasia Types 1 and 2Journal of Oncology, 2012
- Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch SyndromeJAMA, 2011
- Mutation Analysis of the APC Gene in a Chinese FAP Pedigree with Unusual PhenotypeISRN Gastroenterology, 2011
- PTEN hamartoma tumor syndrome: An overviewGenetics in Medicine, 2009
- Inheritance of colorectal cancerDrug Discovery Today: Disease Mechanisms, 2007
- Diagnosis and current management of retinoblastomaOncogene, 2006
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Clinical studies of multiple endocrine neoplasia type 1 (MEN1)QJM: An International Journal of Medicine, 1996